These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 7844919)

  • 21. Phase II clinical trial of combined natural interferon-beta plus recombinant interferon-gamma treatment of chronic hepatitis B.
    Musch E; Högemann B; Gerritzen A; Fischer HP; Wiese M; Kruis W; Malek M; Gugler R; Schmidt G; Huchzermeyer H; Gerlach U; Dengler HJ; Sauerbruch T
    Hepatogastroenterology; 1998; 45(24):2282-94. PubMed ID: 9951911
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Acute renal insufficiency in renal transplants treated with interferon-alpha for chronic hepatitis C].
    Rostaing L; Modesto A; Baron E; Cisterne JM; Chabannier MH; Tkaczuk J; Durand D; Suc JM
    Nephrologie; 1996; 17(4):247-54. PubMed ID: 8768457
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Interferon-induced sarcoidosis.
    Doyle MK; Berggren R; Magnus JH
    J Clin Rheumatol; 2006 Oct; 12(5):241-8. PubMed ID: 17023810
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Peripheral neuropathy during a second cycle of treatment with high doses of interferon-alpha in a patient with hepatitis C, and a review of the literature].
    Téllez-Zenteno JF; Negrete-Pulido O; Nuñez M; Estañol-Vidal B; García-Ramos G
    Rev Neurol; 2002 Oct 1-15; 35(7):644-6. PubMed ID: 12389150
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Inclusion body myositis after interferon-alpha treatment in a patient with HCV and HTLV-1 infection].
    Warabi Y; Matsubara S; Mizutani T; Hayashi H
    Rinsho Shinkeigaku; 2004 Sep; 44(9):609-14. PubMed ID: 15515704
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of the long-term effects of treatment with oral and parenteral interferon alpha in chronic viral hepatitis patients.
    Zielińska W; Korczak-Rogoń A; Paszkiewicz J; Kowalik M; Cummins JM; Georgiades JA
    Arch Immunol Ther Exp (Warsz); 1996; 44(5-6):359-66. PubMed ID: 9017152
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Severe thrombocytopenia during interferon-alpha therapy for chronic active hepatitis C associated with systemic lupus erythematosus].
    Kimura Y; Kajiyama K; Nomura H; Shiraishi G
    Fukuoka Igaku Zasshi; 1994 Nov; 85(11):329-33. PubMed ID: 7851835
    [TBL] [Abstract][Full Text] [Related]  

  • 28. T cells subtypes in a patient with interferon-alpha induced sarcoidosis.
    Monsuez JJ; Carcelain G; Charniot JC; Barrière J; Duclos-Vallée JC; Parent F; Autran B
    Am J Med Sci; 2009 Jan; 337(1):60-2. PubMed ID: 18941406
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of treatment with two different doses of leukocyte interferon alpha in patients with chronic hepatitis C.
    Laghi V; Toccaceli F; Rosati S; Monini A; Grimaldi M; Foglianti G; Canova N; Palazzini E
    Hepatogastroenterology; 1997; 44(16):1182-6. PubMed ID: 9261621
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Subcutaneous nodular sarcoidosis and systemic involvement successfully treated with doxycycline.
    El Sayed F; Dhaybi R; Ammoury A
    J Med Liban; 2006; 54(1):42-4. PubMed ID: 17044634
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sarcoidosis developing after treatment with interferon alpha in a patient with hepatitis C: An association every physician should know.
    Flores-Robles BJ; Sangüesa-Gómez CP; Barbadillo Mateos C; Roustán-Gullón LG; Kovtun I
    Rev Gastroenterol Mex; 2017; 82(2):185-186. PubMed ID: 27161792
    [No Abstract]   [Full Text] [Related]  

  • 32. Concurrent antiphospholipid syndrome and cutaneous [corrected] sarcoidosis due to interferon alfa and ribavirin treatment for hepatitis C.
    Shinohara MM; Davis C; Olerud J
    J Drugs Dermatol; 2009 Sep; 8(9):870-2. PubMed ID: 19746680
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sarcoidosis induced by interferon-α in melanoma patients: incidence, clinical manifestations, and management strategies.
    Heinzerling LM; Anliker MD; Müller J; Schlaeppi M; von Moos R
    J Immunother; 2010 Oct; 33(8):834-9. PubMed ID: 20842053
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cutaneous sarcoidosis in a woman with chronic hepatitis C and interferon therapy: a case report.
    Song K; Das K
    Acta Cytol; 2010; 54(5 Suppl):863-6. PubMed ID: 21053557
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serum hyaluronate predicts response to interferon-alpha therapy in patients with chronic hepatitis C.
    Ueno T; Inuzuka S; Sata M; Koh H; Tamaki S; Kin M; Sugawara H; Sakata R; Torimura T; Tanikawa K
    Hepatogastroenterology; 1995; 42(5):522-7. PubMed ID: 8751209
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Sarcoidosis, myasthenia gravis and anterior ischaemic optic neuropathy: severe side effects of adjuvant interferon-alpha-therapy in malignant melanoma?].
    Kreutzer K; Bonnekoh B; Franke I; Ulrich J; Gollnick H
    J Dtsch Dermatol Ges; 2004 Aug; 2(8):689-94. PubMed ID: 16279234
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lymphoblastoid alpha-interferon for chronic hepatitis C: a randomized controlled study.
    Castilla A; Camps-Bansell J; Civeira MP; Prieto J
    Am J Gastroenterol; 1993 Feb; 88(2):233-9. PubMed ID: 8424427
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Systemic sarcoidosis after treatment with pegylated interferon-alpha].
    Le Bras M; Hervier B; Wastiaux H; Masseau A; Durant C; Jossic F; Hamidou M
    Rev Med Interne; 2010 Apr; 31(4):e11-3. PubMed ID: 20153094
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Asymptomatic systemic sarcoidosis arising 5 years after IFN-alpha treatment for chronic hepatitis C: a new challenge for clinicians.
    Tortorella C; Napoli N; Panella E; Antonaci A; Gentile A; Antonaci S
    J Interferon Cytokine Res; 2004 Nov; 24(11):655-8. PubMed ID: 15684818
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evolution of previous sarcoidosis under type 1 interferons given for severe associated disease.
    Charlier C; Nunes H; Trinchet JC; Roullet E; Mouthon L; Beaugrand M; Valeyre D
    Eur Respir J; 2005 Mar; 25(3):570-3. PubMed ID: 15738304
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.